These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 20042638)

  • 1. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.
    Lim S; Janzer A; Becker A; Zimmer A; Schüle R; Buettner R; Kirfel J
    Carcinogenesis; 2010 Mar; 31(3):512-20. PubMed ID: 20042638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
    Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
    Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.
    Schulte JH; Lim S; Schramm A; Friedrichs N; Koster J; Versteeg R; Ora I; Pajtler K; Klein-Hitpass L; Kuhfittig-Kulle S; Metzger E; Schüle R; Eggert A; Buettner R; Kirfel J
    Cancer Res; 2009 Mar; 69(5):2065-71. PubMed ID: 19223552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells.
    Yu SE; Jang YK
    Biochem Biophys Res Commun; 2012 Oct; 427(2):336-42. PubMed ID: 23000163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
    Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
    Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.
    Zhu Q; Liu C; Ge Z; Fang X; Zhang X; Strååt K; Björkholm M; Xu D
    PLoS One; 2008 Jan; 3(1):e1446. PubMed ID: 18197256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors.
    Schildhaus HU; Riegel R; Hartmann W; Steiner S; Wardelmann E; Merkelbach-Bruse S; Tanaka S; Sonobe H; Schüle R; Buettner R; Kirfel J
    Hum Pathol; 2011 Nov; 42(11):1667-75. PubMed ID: 21531005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
    Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
    Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cell-active lysine specific demethylase 1-selective inhibitors.
    Ueda R; Suzuki T; Mino K; Tsumoto H; Nakagawa H; Hasegawa M; Sasaki R; Mizukami T; Miyata N
    J Am Chem Soc; 2009 Dec; 131(48):17536-7. PubMed ID: 19950987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LSD1 is required for chromosome segregation during mitosis.
    Lv S; Bu W; Jiao H; Liu B; Zhu L; Zhao H; Liao J; Li J; Xu X
    Eur J Cell Biol; 2010 Jul; 89(7):557-63. PubMed ID: 20189264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells.
    Zhu Q; Huang Y; Marton LJ; Woster PM; Davidson NE; Casero RA
    Amino Acids; 2012 Feb; 42(2-3):887-98. PubMed ID: 21805138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer.
    Yao C; Lin Y; Ye CS; Bi J; Zhu YF; Wang SM
    Chin Med J (Engl); 2007 Oct; 120(20):1766-72. PubMed ID: 18028768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.
    Hui R; Macmillan RD; Kenny FS; Musgrove EA; Blamey RW; Nicholson RI; Robertson JF; Sutherland RL
    Clin Cancer Res; 2000 Jul; 6(7):2777-87. PubMed ID: 10914724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
    Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
    Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
    Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.
    Aaltonen K; Amini RM; Landberg G; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H; Blomqvist C
    Breast Cancer Res Treat; 2009 Jan; 113(1):75-82. PubMed ID: 18240019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.